Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma.

[1]  M. Schlumberger,et al.  Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? , 2016, The lancet. Diabetes & endocrinology.

[2]  A. Tischler,et al.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. , 2016, JAMA oncology.

[3]  R. Tuttle,et al.  Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine. , 2016, The Journal of clinical endocrinology and metabolism.

[4]  A. Miyauchi,et al.  A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma. , 2016, Thyroid : official journal of the American Thyroid Association.

[5]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[6]  A. Miyauchi,et al.  Revisiting Low-Risk Thyroid Papillary Microcarcinomas Resected Without Observation: Was Immediate Surgery Necessary? , 2016, World Journal of Surgery.

[7]  I. Ganly,et al.  Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases. , 2015, Human pathology.

[8]  G. Ronga,et al.  BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study , 2015, Modern Pathology.

[9]  J. Shah,et al.  Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It? , 2015, Thyroid : official journal of the American Thyroid Association.

[10]  Amy Y. Chen,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[11]  J. Fagin,et al.  Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Bishop,et al.  BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Shah,et al.  The impact of nodal status on outcome in older patients with papillary thyroid cancer. , 2014, Surgery.

[14]  R. Tuttle,et al.  Update on differentiated thyroid cancer staging. , 2014, Endocrinology and metabolism clinics of North America.

[15]  M. Hirokawa,et al.  Papillary thyroid microcarcinoma might progress during pregnancy. , 2014, Thyroid : official journal of the American Thyroid Association.

[16]  Louise Davies,et al.  Current thyroid cancer trends in the United States. , 2014, JAMA otolaryngology-- head & neck surgery.

[17]  T. Michael,et al.  Observing Micopapillary Thyroid Cancers , 2014 .

[18]  A. Miyauchi,et al.  Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. , 2014, Thyroid : official journal of the American Thyroid Association.

[19]  P. Ladenson,et al.  Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. , 2013, JAMA.

[20]  Sebastiano Filetti,et al.  Papillary thyroid cancer: time course of recurrences during postsurgery surveillance. , 2013, The Journal of clinical endocrinology and metabolism.

[21]  S. Mandel,et al.  The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. , 2012, Thyroid : official journal of the American Thyroid Association.

[22]  A. Pinchera,et al.  The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. , 2012, The Journal of clinical endocrinology and metabolism.

[23]  J. Shah,et al.  Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. , 2012, Surgery.

[24]  S. Filetti,et al.  Management of papillary thyroid cancer patients in absence of postoperative radioiodine remnant ablation: tailoring follow-up by neck sonography. , 2011, The Journal of clinical endocrinology and metabolism.

[25]  R. Lloyd,et al.  Papillary Thyroid Carcinoma Variants , 2011, Head and neck pathology.

[26]  J. Shah,et al.  Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. , 2010, Thyroid : official journal of the American Thyroid Association.

[27]  R. Ghossein.  Encapsulated Malignant Follicular Cell-Derived Thyroid Tumors , 2010, Endocrine pathology.

[28]  Z. Baloch,et al.  Encapsulated classic and follicular variants of papillary thyroid carcinoma: comparative clinicopathologic study. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[29]  I. Sugitani,et al.  Management of low-risk papillary thyroid carcinoma: Unique conventional policy in Japan and our efforts to improve the level of evidence , 2010, Surgery Today.

[30]  I. Sugitani,et al.  Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and Outcomes , 2010, World Journal of Surgery.

[31]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[32]  R. Ghossein.  Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin. , 2009, Archives of pathology & laboratory medicine.

[33]  M. Xing,et al.  BRAF Mutation in Papillary Thyroid Microcarcinoma: The Promise of Better Risk Management , 2009, Annals of surgical oncology.

[34]  A. Miyauchi,et al.  An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients , 2009, World Journal of Surgery.

[35]  T. Sebo,et al.  Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. , 2008, Surgery.

[36]  Yuri E Nikiforov,et al.  Thyroid carcinoma: molecular pathways and therapeutic targets , 2008, Modern Pathology.

[37]  E. Mazzaferri.  Management of low-risk differentiated thyroid cancer. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[38]  I. Hay.  Management of patients with low-risk papillary thyroid carcinoma. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[39]  P. Ladenson,et al.  BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. , 2005, The Journal of clinical endocrinology and metabolism.

[40]  Q. Duh,et al.  Follicular thyroid carcinoma: Histology and prognosis , 2004, Cancer.

[41]  Koichi Ito,et al.  Lymph Node Metastasis From 259 Papillary Thyroid Microcarcinomas: Frequency, Pattern of Occurrence and Recurrence, and Optimal Strategy for Neck Dissection , 2003, Annals of surgery.

[42]  Z. Baloch,et al.  Follicular-patterned lesions of the thyroid: the bane of the pathologist. , 2002, American journal of clinical pathology.

[43]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.